Here, ccRCC patients featuring low TMEM25 expression exhibited a lowered sensitivity to erlotinib compared to those with elevated TMEM25 expression (Figure 8A–8P). The gene discussed is TMEM25; the disease is nonpapillary renal cell carcinoma.